SecSonar.com

CVS Health Corporation (CVS)

CVS Health Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CVS Health Corporation (CVS) is a Medical - Healthcare Plans company based in US with a market capitalization of $116.5B. Revenue grew 7.8% year-over-year and the company generated $7.8B in free cash flow. This page tracks CVS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 300K employees · IPO Nov 20, 1996

Valuation

Valuation & price

$95.89 · as of May 17, 2026 · -8.5% vs 52w high

68.9

P/E ratio

Latest-FY diluted EPS

1.55

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$105$82.36$60.00Jul 25Dec 25Jul 26Jul 7, 25$66.68Jul 9, 25$66.66Jul 11, 25$64.78Jul 15, 25$63.94Jul 17, 25$63.30Jul 21, 25$61.64Jul 23, 25$61.85Jul 25, 25$60.70Jul 29, 25$60.00Jul 31, 25$62.10Aug 4, 25$61.45Aug 6, 25$63.52Aug 11, 25$64.88Aug 13, 25$65.90Aug 15, 25$68.60Aug 19, 25$70.97Aug 21, 25$71.43Aug 25, 25$71.21Aug 27, 25$71.93Aug 29, 25$73.15Sep 3, 25$73.32Sep 5, 25$73.78Sep 9, 25$71.75Sep 11, 25$74.67Sep 16, 25$73.48Sep 18, 25$74.42Sep 22, 25$75.13Sep 24, 25$76.38Sep 26, 25$75.77Sep 30, 25$75.39Oct 2, 25$77.45Oct 6, 25$76.84Oct 8, 25$76.93Oct 10, 25$77.90Oct 14, 25$79.66Oct 16, 25$81.37Oct 21, 25$83.04Oct 23, 25$81.07Oct 27, 25$82.45Oct 29, 25$80.60Oct 31, 25$78.15Nov 4, 25$78.08Nov 6, 25$78.66Nov 10, 25$77.54Nov 12, 25$80.26Nov 14, 25$77.81Nov 18, 25$77.94Nov 20, 25$76.04Nov 25, 25$78.47Nov 28, 25$80.36Dec 2, 25$77.62Dec 4, 25$76.75Dec 8, 25$76.53Dec 10, 25$78.97Dec 12, 25$79.42Dec 16, 25$78.29Dec 18, 25$77.79Dec 22, 25$78.36Dec 24, 25$79.12Dec 29, 25$80.02Jan 2, 26$80.13Jan 6, 26$80.70Jan 8, 26$80.60Jan 12, 26$80.36Jan 14, 26$79.33Jan 16, 26$78.60Jan 21, 26$81.49Jan 23, 26$83.01Jan 27, 26$72.00Jan 29, 26$74.44Feb 2, 26$75.42Feb 4, 26$75.24Feb 9, 26$75.77Feb 11, 26$77.02Feb 13, 26$78.48Feb 18, 26$77.75Feb 20, 26$76.69Feb 24, 26$74.18Feb 26, 26$78.01Mar 2, 26$81.66Mar 4, 26$80.57Mar 6, 26$77.92Mar 10, 26$76.32Mar 12, 26$76.07Mar 17, 26$74.81Mar 19, 26$71.86Mar 23, 26$71.29Mar 25, 26$72.18Mar 27, 26$70.08Mar 31, 26$71.82Apr 2, 26$73.49Apr 7, 26$78.22Apr 9, 26$78.84Apr 13, 26$78.09Apr 15, 26$74.99Apr 17, 26$77.30Apr 22, 26$76.43Apr 24, 26$77.94Apr 28, 26$80.98Apr 30, 26$83.29May 4, 26$82.01May 6, 26$86.86May 8, 26$90.55May 12, 26$95.15May 14, 26$97.15May 18, 26$95.99May 20, 26$93.28May 22, 26$93.26May 28, 26$92.97Jun 1, 26$90.62Jun 3, 26$91.37Jun 5, 26$95.93Jun 9, 26$97.06Jun 11, 26$100.48Jun 15, 26$100.68Jun 17, 26$99.16Jun 22, 26$101.30Jun 24, 26$101.87Jun 26, 26$104.34Jul 2, 26$104.72
$58.7552-week range$104.81
Loading valuation history…

Fundamentals

Key fundamentals

$116.5B

Market cap

7.8%

Revenue growth (YoY)

13.8%

Gross margin

$7.8B

Free cash flow (USD)

$82.9B

Net debt

0.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$177.5BFY 2017$184.8BFY 2018$194.6BFY 2019$256.8BFY 2020$268.7BFY 2021$292.1BFY 2022$322.5BFY 2023$357.8BFY 2024$372.8BFY 2025$402.1B
$177.5B$402.1B

Free cash flow by year

2016 → 2025

FY 2016$7.9BFY 2017$6.1BFY 2018$6.8BFY 2019$10.4BFY 2020$13.4BFY 2021$15.7BFY 2022$13.4BFY 2023$10.4BFY 2024$6.3BFY 2025$7.8B
$7.9B$7.8B

Gross margin by year

2021 → 2025

FY 202117.8%FY 202216.9%FY 202315.2%FY 202413.8%FY 202513.8%
17.8%13.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationMay 22, 2026Filing
  • Insider sellInsider Sell $317.5MROBBINS LARRY · Director · $317.5MMay 21, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 18, 2026Filing
  • Insider sellInsider Sell $6.2MMandadi Tilak · EVP, Chief Exp & Tech Officer · $6.2MMay 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is CVS Health Corporation's market cap?

CVS Health Corporation (CVS) has a market capitalization of $116.5B.

What is CVS's P/E ratio?

CVS trades at a price-to-earnings ratio of 68.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is CVS's price-to-book (P/B) ratio?

CVS trades at 1.55 times book value per share.

Are insiders buying CVS stock?

SEC Form 4 filings show no open-market insider buys at CVS Health Corporation in the last 90 days (2 sells).

Same arena

Related companies in Medical - Healthcare Plans

ELV

Elevance Health Inc.

$85.6B

CI

Cigna Corporation

$73.7B

HUM

Humana Inc.

$36.8B

CNC

Centene Corporation

$29.2B

MOH

Molina Healthcare, Inc.

$9.1B

OSCR

Oscar Health, Inc.

$5.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.